Why the study?
Does an implantable cardioverter defibrillator with biventricular pacing suppress drug-refractory ventricular tachycardia in a patient with severe congestive heart failure and ischemic disease?
Does an implantable cardioverter defibrillator with biventricular pacing suppress drug-refractory ventricular tachycardia in a patient with severe congestive heart failure and ischemic disease?
Biventricular pacing via an ICD completely suppressed drug-refractory ventricular tachycardia in a patient with severe heart failure and ischemic heart disease.
May support biventricular pacing for refractory VT in ischemic HF; single case leaves open need for controlled trials.
GARRIGUE, S., et al. : Treatment of Drug Refractory Ventricular Tachycardia by Biventricular Pacing. In a patient with severe congestive heart failure and ischemic disease, frequent episodes of ventricular tachycardia were completely suppressed by an implantable cardioverter defibrillator with biventricular pacing
No takes yet. Share an insight, caveat, or question.
Garrigue et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: